These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26245276)

  • 21. Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.
    Wang Y; Wu M; Ai C; Wang Y
    Int J Mol Sci; 2015 Aug; 16(9):20118-38. PubMed ID: 26307982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural insights of JAK2 inhibitors: pharmacophore modeling and ligand-based 3D-QSAR studies of pyrido-indole derivatives.
    Gade DR; Kunala P; Raavi D; Reddy PK; Prasad RV
    J Recept Signal Transduct Res; 2015 Apr; 35(2):189-201. PubMed ID: 25140764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
    Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacophore modeling, 3D-QSAR and DFT studies of IWR small-molecule inhibitors of Wnt response.
    Kirubakaran P; Karthikeyan M
    J Recept Signal Transduct Res; 2013 Oct; 33(5):276-85. PubMed ID: 23914783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
    Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
    J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.
    Xiao Z; Varma S; Xiao YD; Tropsha A
    J Mol Graph Model; 2004 Oct; 23(2):129-38. PubMed ID: 15363455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of potent antihypertensive ligands substituted imidazolyl biphenyl sulfonylureas analogs as angiotensin II AT
    Sharma MC
    Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR studies on imidazopyrazine derivatives as Aurora A kinase inhibitors.
    Leng Y; Lu T; Yuan HL; Liu HC; Lu S; Zhang WW; Jiang YL; Chen YD
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):705-30. PubMed ID: 22971111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors.
    Qin J; Xi L; Du J; Liu H; Yao X
    Chem Biol Drug Des; 2010 Dec; 76(6):527-37. PubMed ID: 21040493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSAR and Pharmacophore Mapping Studies on Benzothiazinimines to Relate their Structural Features with anti-HIV Activity.
    Geethaavacini G; Poh GP; Yan LY; Deepashini R; Shalini S; Harish R; Sureshkumar K; Ravichandran V
    Med Chem; 2018; 14(7):733-740. PubMed ID: 29807521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors.
    Du J; Xi L; Lei B; Lu J; Li J; Liu H; Yao X
    J Comput Chem; 2010 Nov; 31(15):2783-93. PubMed ID: 20839304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional quantitative structure-activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors.
    Shaikh AR; Ismael M; Del Carpio CA; Tsuboi H; Koyama M; Endou A; Kubo M; Broclawik E; Miyamoto A
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5917-25. PubMed ID: 16989998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A structure-activity relationship study of imidazole-5-carboxylic acids derivatives as angiotensin II receptor antagonists combining 2D and 3D QSAR methods.
    Sharma MC
    Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR modeling of photosynthesis-inhibiting nostoclide derivatives.
    Teixeira RR; Pinheiro PF; Barbosa LC; Carneiro JW; Forlani G
    Pest Manag Sci; 2010 Feb; 66(2):196-202. PubMed ID: 19798697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors.
    Xie H; Qiu K; Xie X
    Int J Mol Sci; 2014 Nov; 15(11):20927-47. PubMed ID: 25405729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative bioactivity prediction and pharmacophore identification for benzotriazine derivatives using the electron conformational-genetic algorithm in QSAR.
    Sahin K; Sarıpınar E; Yanmaz E; Geçen N
    SAR QSAR Environ Res; 2011 Jun; 22(3):217-38. PubMed ID: 21391137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors.
    Xie H; Chen L; Zhang J; Xie X; Qiu K; Fu J
    Int J Mol Sci; 2015 May; 16(6):12307-23. PubMed ID: 26035757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore mapping and electronic feature analysis for a series of nitroaromatic compounds with antitubercular activity.
    Tawari NR; Degani MS
    J Comput Chem; 2010 Mar; 31(4):739-51. PubMed ID: 19569203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
    Reddy KK; Singh SK
    Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.
    Chen Y; Li H; Tang W; Zhu C; Jiang Y; Zou J; Yu Q; You Q
    Eur J Med Chem; 2009 Jul; 44(7):2868-76. PubMed ID: 19136179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.